Evidence-Based Medicine

Evidence-Based Medicine

Apixaban in Patients With ESRD and Atrial Fibrillation

By

Alan Ehrlich, MD

Evidence-Based Medicine

Assessment of Dual Antiplatelet Therapy After Stroke, TIA

By

Alan Ehrlich, MD

Evidence-Based Medicine

Albiglutide Reduces Major CV Events in Patients With Type II Diabetes and Known CVD

By

Alan Ehrlich, MD

Evidence-Based Medicine

Physical Therapy May Allow Patients With Meniscal Tears to Avoid Surgery

By

Alan Ehrlich, MD

Evidence-Based Medicine

Emollient Bath Additives Ineffective for Atopic Dermatitis in Children

By

Alan Ehrlich, MD

Evidence-Based Medicine

Adjuvant Chemo With Endocrine Therapy for HR+/HER2- Breast Cancer

By

Alan Ehrlich, MD

Evidence-Based Medicine

Limited Formula Supplementation May Not Adversely Affect Breastfeeding

By

Alan Ehrlich, MD

Evidence-Based Medicine

Budesonide/Formoterol for the Prevention of Serious Asthma Exacerbations

By

Alan Ehrlich, MD

Evidence-Based Medicine

Antenatal steroids may improve respiratory outcomes for late preterm births

By

Alan Ehrlich, MD

Evidence-Based Medicine

Regular proton pump inhibitor use associated with an increased risk of dementia in the elderly

By

Alan Ehrlich, MD

Evidence-Based Medicine

Resumption of antithrombotic therapy after gastrointestinal bleeding in patients with atrial fibrillation

By

Alan Ehrlich, MD

Evidence-Based Medicine

Risk of Alzheimer dementia after androgen deprivation therapy

By

Alan Ehrlich, MD

Evidence-Based Medicine

Screening and treating pregnant women with asymptomatic bacteriuria may not be helpful

By

Alan Ehrlich, MD

Evidence-Based Medicine

Glasgow Coma Scale may underestimate severity of isolated traumatic brain injury in patients aged ≥65 years

By

Alan Ehrlich, MD

Evidence-Based Medicine

In patients with first unprovoked venous thromboembolism, adding CT to limited cancer screening may not lead to statistically higher rate of cancer detection

By

Alan Ehrlich, MD

Evidence-Based Medicine

In patients without 
CVD or diabetes, pooled cohort equations may underestimate risk for CV event if other risk factors are present

By

Alan Ehrlich, MD

Evidence-Based Medicine

Palliative chemotherapy may reduce quality of life in some patients with end-stage cancer

By

Alan Ehrlich, MD

Evidence-Based Medicine

Denosumab may reduce the risk of fracture in women with breast cancer on aromatase inhibitor therapy

By

Alan Ehrlich, MD

Evidence-Based Medicine

Initiating antiretroviral therapy in HIV patients with CD4 T-cell counts >500 cells/mcL

By

Alan Ehrlich, MD

Evidence-Based Medicine

Vitamin D supplementation does not improve functional outcomes in postmenopausal women

By

Alan Ehrlich, MD